US 12,133,763 B2
Ultrasound imaging
Martin F. Burns, Los Angeles, CA (US)
Assigned to BRUIN BIOMETRICS, LLC, Los Angeles, CA (US)
Appl. No. 17/776,759
Filed by BRUIN BIOMETRICS, LLC, Los Angeles, CA (US)
PCT Filed Nov. 11, 2020, PCT No. PCT/US2020/060062
§ 371(c)(1), (2) Date May 13, 2022,
PCT Pub. No. WO2021/096992, PCT Pub. Date May 20, 2021.
Claims priority of provisional application 63/108,627, filed on Nov. 2, 2020.
Claims priority of provisional application 62/935,635, filed on Nov. 14, 2019.
Prior Publication US 2022/0401063 A1, Dec. 22, 2022
Int. Cl. A61B 8/00 (2006.01); A61B 8/08 (2006.01)
CPC A61B 8/085 (2013.01) [A61B 8/0858 (2013.01); A61B 8/461 (2013.01); A61B 8/5207 (2013.01); A61B 8/5223 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for reducing the incidence of wound development in patients admitted to a care facility, the method comprising the steps of:
a. evaluating a patient for a risk of tissue damage upon admission to the care facility, wherein evaluating comprises:
i. obtaining a sonography image of the patient at one or more body locations at risk of wound development; and
ii. determining a number of sonographic characteristics of tissue damage present in the sonography image;
b. if the number of sonographic characteristics present is below or equal to a first threshold, performing (1) administering a level-0 intervention, and (2) obtaining a subsequent sonography image of the one or more body locations after a time interval associated with level-0 transpires; and
c. if the number of sonographic characteristics present exceeds the first threshold, performing (1) administering a level-N intervention, and (2) obtaining a subsequent sonography image of the one or more body locations after a time interval associated with level-N transpires, and wherein N is an integer ≥1.